Citations (57)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (15)
Gary W. Dowsett, Duane Duncan, Andrea Waling, Steven Angelides & Gemma Nourse. (2023) Men, bodywork, health and the potentiality of performance and image-enhancing drugs. Health Sociology Review 32:3, pages 341-356.
Read now
Read now
Vassilis Barkoukis, Peter R. Harris, Richard Rowe & Lambros Lazuras. (2023) Self-Affirmation and Image/Performance Enhancing Drug Use in Recreational Exercise. Research Quarterly for Exercise and Sport 94:3, pages 698-706.
Read now
Read now
Evelyn Hearne, Amanda Atkinson, Ian Boardley, Jim McVeigh & Marie Claire Van Hout. (2022) ‘Sustaining masculinity’: a scoping review of anabolic androgenic steroid use by older males. Drugs: Education, Prevention and Policy 0:0, pages 1-27.
Read now
Read now
Orlanda Harvey, Margarete Parrish, Edwin van Teijlingen & Steven Trenoweth. (2022) Libido as a motivator for starting and restarting non-prescribed anabolic androgenic steroid use among men: a mixed-methods study. Drugs: Education, Prevention and Policy 29:3, pages 276-288.
Read now
Read now
Matthew Dunn, Kyle J. D. Mulrooney, Dean Biddau, Fiona H. McKay & Richard Henshaw. (2022) ‘Bali over the Counter’: Exploring the Overseas Use and Acquisition of Anabolic-androgenic Steroids. Deviant Behavior 43:4, pages 447-460.
Read now
Read now
Jorge Marcos-Marcos, José Tomás Mateos, Àngel Gasch-Gallén & Carlos Álvarez-Dardet. (2021) Men’s health across the life course: A gender relational (critical) overview. Journal of Gender Studies 30:7, pages 772-785.
Read now
Read now
Annica Börjesson, Margaretha Ekebergh, Marja-Liisa Dahl, Lena Ekström, Mikael Lehtihet & Veronica Vicente. (2021) Men´s experiences of using anabolic androgenic steroids. International Journal of Qualitative Studies on Health and Well-being 16:1.
Read now
Read now
Orlanda Harvey & Margarete Parrish. (2020) Social Work Implications of Anabolic–Androgenic Steroid Use, Particularly Among Young People: A Literature Review. Practice 32:3, pages 209-228.
Read now
Read now
Katinka van de Ven, Renee Zahnow, Jim McVeigh & Adam Winstock. (2020) The modes of administration of anabolic-androgenic steroid (AAS) users: are non-injecting people who use steroids overlooked?. Drugs: Education, Prevention and Policy 27:2, pages 131-135.
Read now
Read now
B. Jacka, B. Larance, J. Copeland, L. Burns, M. Farrell, E. Jackson & L. Degenhardt. (2020) Health care engagement behaviors of men who use performance- and image-enhancing drugs in Australia. Substance Abuse 41:1, pages 139-145.
Read now
Read now
Geoff Bates, David Tod, Conan Leavey & Jim McVeigh. (2019) An evidence-based socioecological framework to understand men’s use of anabolic androgenic steroids and inform interventions in this area. Drugs: Education, Prevention and Policy 26:6, pages 484-492.
Read now
Read now
Renae Fomiatti, J. R. Latham, Suzanne Fraser, David Moore, Kate Seear & Campbell Aitken. (2019) A ‘messenger of sex’? Making testosterone matter in motivations for anabolic-androgenic steroid injecting. Health Sociology Review 28:3, pages 323-338.
Read now
Read now
Mohammad Hassan Saati Asr, Saeed Bashirian, Rashid Heidari Moghadam, Majid Barati & Babak Moeini. (2018) Personal and psychosocial factors associated with anabolic-androgenic steroid use among Iranian male bodybuilders. Journal of Substance Use 23:4, pages 390-395.
Read now
Read now
Jim McVeigh & Emma Begley. (2017) Anabolic steroids in the UK: an increasing issue for public health. Drugs: Education, Prevention and Policy 24:3, pages 278-285.
Read now
Read now
Ask Vest Christiansen, Anders Schmidt Vinther & Dimitris Liokaftos. (2017) Outline of a typology of men’s use of anabolic androgenic steroids in fitness and strength training environments*. Drugs: Education, Prevention and Policy 24:3, pages 295-305.
Read now
Read now
Articles from other publishers (42)
Nawal Izzat, Rana Abu-Farha, Mea’ad M. Harahsheh & Samar Thiab. (2023) A qualitative assessment of anabolic–androgenic steroid use among gym users in Jordan: motives, perception, and safety. International Journal of Legal Medicine 137:5, pages 1421-1430.
Crossref
Crossref
Luke A. Turnock & Kyle J. D. Mulrooney. (2023) Exploring the Impacts of Rurality on Service Access and Harm Among Image and Performance Enhancing Drug (IPED) Users in a Remote English Region. Contemporary Drug Problems 50:2, pages 232-253.
Crossref
Crossref
Dr Luke Turnock & Dr Nick Gibbs. (2023) Click, click, buy: The market for novel synthetic peptide hormones on mainstream e-commerce platforms in the UK. Performance Enhancement & Health 11:2, pages 100251.
Crossref
Crossref
Pia Johansson Heinsvig, Ask Vest Christiansen, Daniel Ayoubi, Laura Smedegaard Heisel & Christian Lindholst. (2023) Do you get what you see? The illicit doping market in Denmark—An analysis of performance and image enhancing drugs seized by the police over a 1‐year period. Drug Testing and Analysis 15:6, pages 668-677.
Crossref
Crossref
Timothy M. Piatkowski, David L. Neumann & Matthew Dunn. (2023) ‘My mind pretty much went to mush’: A qualitative exploration of trenbolone in the performance and image enhancing drug community. Drug and Alcohol Review.
Crossref
Crossref
Bertrand Fincoeur & Jessica Rullo. 2022. Doping in Sport and Fitness. Doping in Sport and Fitness
139
153
.
Mair Underwood. 2022. Doping in Sport and Fitness. Doping in Sport and Fitness
111
136
.
Mair Underwood. (2022) Anabolics coaching: A necessary evil?. Performance Enhancement & Health 10:3, pages 100233.
Crossref
Crossref
Nicholas Gibbs, Luke Cox & Luke Turnock. (2022) Anabolics coaching: Emic harm reduction or a public health concern?. Performance Enhancement & Health 10:3, pages 100227.
Crossref
Crossref
Timothy M Piatkowski, Leanne M Hides, Katherine M White, Patricia L Obst & Matthew Dunn. (2022) Understanding harm reduction perspectives of performance and image enhancing drug consumers and health care providers. Performance Enhancement & Health 10:3, pages 100223.
Crossref
Crossref
Cornelia Graf, Siyu Qian, Naomi Viret & Amber Lautier. (2022) Knowledge and experience of using performance and image enhancing drugs among attendees of a Needle and Syringe Program in Australia: A qualitative study. Performance Enhancement & Health 10:2, pages 100222.
Crossref
Crossref
Julio X. Amaral, Andrea C. Deslandes, Monica C. Padilha, Leonardo Vieira Neto, Luiz E. Osorio, Francisco Radler Aquino Neto & Marcelo S. Cruz. (2022) No association between psychiatric symptoms and doses of anabolic steroids in a cohort of male and female bodybuilders. Drug Testing and Analysis 14:6, pages 1079-1088.
Crossref
Crossref
Katja M. Shimko, Timothy Piatkowski, Kevin V. Thomas, Naomi Speers, Lance Brooker, Ben J. Tscharke & Jake W. O’Brien. (2021) Performance- and image-enhancing drug use in the community: use prevalence, user demographics and the potential role of wastewater-based epidemiology. Journal of Hazardous Materials 419, pages 126340.
Crossref
Crossref
Juraj Macho, Jiri Mudrak & Pavel Slepicka. (2021) Enhancing the Self: Amateur Bodybuilders Making Sense of Experiences With Appearance and Performance-Enhancing Drugs. Frontiers in Psychology 12.
Crossref
Crossref
Bertrand Fincoeur & Jessica Rullo. (2021) Je pousse donc je suis : du rôle de la musculation et des produits de la performance en prison. Déviance et Société Vol. 45:2, pages 231-263.
Crossref
Crossref
Jesper Andreasson & Thomas Johansson. (2021) Welcome to “Planet Porno”. Journal of Bodies, Sexualities, and Masculinities 2:1, pages 9-30.
Crossref
Crossref
Hagit Bonny-Noach, Ronny Berkovitz & Barak Shapira. (2020) Evaluation of performance-enhancing drugs seized by Israeli enforcement agencies 2012–2017: implications for policy and regulatory change. Israel Journal of Health Policy Research 9:1.
Crossref
Crossref
Hugh Gilmore, Stephen Shannon, Gerard Leavey, Martin Dempster, Shane Gallagher & Gavin Breslin. (2020) Help-Seeking Beliefs Among Anabolic Androgenic Steroid Users Experiencing Side Effects: An Interpretive Phenomenological Analysis. Journal of Clinical Sport Psychology 14:4, pages 359-375.
Crossref
Crossref
David Moore, Aaron Hart, Suzanne Fraser & Kate Seear. (2019) Masculinities, practices and meanings: A critical analysis of recent literature on the use of performance- and image-enhancing drugs among men. Health: An Interdisciplinary Journal for the Social Study of Health, Illness and Medicine 24:6, pages 719-736.
Crossref
Crossref
Charlotte W. Greenway & Clare Price. (2020) Muscle dysmorphia and self-esteem in former and current users of anabolic-androgenic steroids. Performance Enhancement & Health 7:3-4, pages 100154.
Crossref
Crossref
Jesper Andreasson & Thomas Johansson. (2019) (Un)Becoming a Fitness Doper: Negotiating the Meaning of Illicit Drug Use in a Gym and Fitness Context. Journal of Sport and Social Issues 44:1, pages 93-109.
Crossref
Crossref
Suzanne Fraser, Renae Fomiatti, David Moore, Kate Seear & Campbell Aitken. (2020) Is another relationship possible? Connoisseurship and the doctor–patient relationship for men who consume performance and image-enhancing drugs. Social Science & Medicine 246, pages 112720.
Crossref
Crossref
Renae Fomiatti, Emily Lenton, J.R. Latham, Suzanne Fraser, David Moore, Kate Seear & Campbell Aitken. (2020) Maintaining the healthy body: Blood management and hepatitis C prevention among men who inject performance and image-enhancing drugs. International Journal of Drug Policy 75, pages 102592.
Crossref
Crossref
Jesper Andreasson & Thomas JohanssonJesper Andreasson & Thomas Johansson. 2020. Fitness Doping. Fitness Doping
87
113
.
Jesper Andreasson & Thomas JohanssonJesper Andreasson & Thomas Johansson. 2020. Fitness Doping. Fitness Doping
21
46
.
Jesper Andreasson & Thomas JohanssonJesper Andreasson & Thomas Johansson. 2020. Fitness Doping. Fitness Doping
3
19
.
Geoff Bates, Marie-Claire Van Hout, Joseph Tay Wee Teck & Jim McVeigh. (2019) Treatments for people who use anabolic androgenic steroids: a scoping review. Harm Reduction Journal 16:1.
Crossref
Crossref
Orlanda Harvey, Steve Keen, Margarete Parrish & Edwin van Teijlingen. (2019) Support for people who use Anabolic Androgenic Steroids: A Systematic Scoping Review into what they want and what they access. BMC Public Health 19:1.
Crossref
Crossref
Laura Badenes-Ribera, Maria Rubio-Aparicio, Julio Sánchez-Meca, Matteo Angelo Fabris & Claudio Longobardi. (2019) The association between muscle dysmorphia and eating disorder symptomatology: A systematic review and meta-analysis. Journal of Behavioral Addictions 8:3, pages 351-371.
Crossref
Crossref
Kyle J.D Mulrooney, Katinka van de Ven, Jim McVeigh & Rick Collins. (2019) Steroid Madness- has the dark side of anabolic-androgenic steroids (AAS) been over-stated?. Performance Enhancement & Health 6:3-4, pages 98-102.
Crossref
Crossref
Jesper Andreasson & Thomas Johansson. (2019) Bodybuilding and Fitness Doping in Transition. Historical Transformations and Contemporary Challenges. Social Sciences 8:3, pages 80.
Crossref
Crossref
Scott Griffiths, Brendan Jacka, Louisa Degenhardt, Stuart B. Murray & Briony Larance. (2018) Physical appearance concerns are uniquely associated with the severity of steroid dependence and depression in anabolic-androgenic steroid users. Drug and Alcohol Review 37:5, pages 664-670.
Crossref
Crossref
Charlotte W. Greenway & Clare Price. (2018) A qualitative study of the motivations for anabolic-androgenic steroid use: The role of muscle dysmorphia and self-esteem in long-term users. Performance Enhancement & Health 6:1, pages 12-20.
Crossref
Crossref
Boden Tighe, Matthew Dunn, Fiona H. McKay & Timothy Piatkowski. (2017) Information sought, information shared: exploring performance and image enhancing drug user-facilitated harm reduction information in online forums. Harm Reduction Journal 14:1.
Crossref
Crossref
Katinka van de Ven & Rosa Koenraadt. (2017) Exploring the relationship between online buyers and sellers of image and performance enhancing drugs (IPEDs): Quality issues, trust and self-regulation. International Journal of Drug Policy 50, pages 48-55.
Crossref
Crossref
Rebekah Brennan, John S.G. Wells & Marie Claire Van Hout. (2017) The injecting use of image and performance-enhancing drugs (IPED) in the general population: a systematic review. Health & Social Care in the Community 25:5, pages 1459-1531.
Crossref
Crossref
Renee Zahnow, Jim McVeigh, Jason Ferris & Adam Winstock. (2017) Adverse Effects, Health Service Engagement, and Service Satisfaction Among Anabolic Androgenic Steroid Users. Contemporary Drug Problems 44:1, pages 69-83.
Crossref
Crossref
Gisella Hanley Santos & Ross Coomber. (2017) The risk environment of anabolic–androgenic steroid users in the UK: Examining motivations, practices and accounts of use. International Journal of Drug Policy 40, pages 35-43.
Crossref
Crossref
Katinka van de Ven & Kyle J.D. Mulrooney. (2017) Social suppliers: Exploring the cultural contours of the performance and image enhancing drug (PIED) market among bodybuilders in the Netherlands and Belgium. International Journal of Drug Policy 40, pages 6-15.
Crossref
Crossref
Mair Underwood. (2017) Exploring the social lives of image and performance enhancing drugs: An online ethnography of the Zyzz fandom of recreational bodybuilders. International Journal of Drug Policy 39, pages 78-85.
Crossref
Crossref
Katinka van de Ven. (2016) ‘Blurred lines’: Anti-doping, national policies, and the performance and image enhancing drug (PIED) market in Belgium and The Netherlands. Performance Enhancement & Health 4:3-4, pages 94-102.
Crossref
Crossref
Dominic Sagoe, Jim McVeigh, Astrid Bjørnebekk, Marie-Stella Essilfie, Cecilie Schou Andreassen & Ståle Pallesen. (2015) Polypharmacy among anabolic-androgenic steroid users: a descriptive metasynthesis. Substance Abuse Treatment, Prevention, and Policy 10:1.
Crossref
Crossref